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Coronary artery bypass graftAbstract Background: Familial hypercholesterolemia (FH) is a genetic disorder caused by a
mutation of the gene for the low density lipoprotein receptor. This mutation can lead to elevated
plasma cholesterol levels and subsequently to premature coronary artery disease. Management of
patients with FH is complicated and surgery is accompanied by high risk, even in skillful hands.
Case presentation: A 12-year-old female patient was referred to our department in January 2013
with chest pain and dyspnea. Her history showed that he had documented evidence of homozygous
HF (HFH) since 2 years of age and that she underwent a Ross–Konno procedure for valvular aortic
stenosis, 3 years ago. Electrocardiography showed ST depression in the inferolateral derivations
and ST elevation in aVr. The echocardiography showed LV systolic dysfunction and important
mitral regurgitation. Coronary angiography demonstrated stenosis in the distal part of the left main
and severe three vessel coronary artery disease. The patient presented critical acute myocardial
ischemia immediately after coronary angiography. She was referred for surgery. The left anterior
descending artery was bypassed using saphenous vein and both right coronary artery and marginal
artery using sequential saphenous vein. The mitral valve was replaced with mechanic prosthesis.
The postoperative course was uneventful. She was prescribed atorvastatin accompanied by chole-
styramine and diet modulation.
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Familial hypercholesterolemia (FH) is a genetic disorder caused
by a mutation of the gene for the low-density lipoprotein
receptor. This mutation can lead to elevated plasma cholesterol
levels and subsequently to premature coronary artery disease. It
may also lead to valvular and supravalvular aortic stenosis.
Management of patients with FH is complicated and
surgery is accompanied by high risk, even in skillful hands.
Herein, we present a young patient with Homozygous FH
(HFH) who presented with dyspnea and chest pain caused
by coronary arteries stenosis and was treated with coronary
artery bypass graft (CABG) surgery at the age of 12 years.
2. Case presentation
A 12-year-old female patient was referred to our department in
January 2013 with chest pain and dyspnea. Her history showed
that he had documented evidence of HFH since 2 years of age
and that she had received lipid lowering drugs such as
atorvastatin and cholestyramine. Besides, she underwent a
Ross–Konno procedure for valvular aortic stenosis, 3 years
ago.
On physical examination, she had multiple xanthomas
(Fig. 1). Cardiac examination revealed sinus tachycardia of
120 bpm, blood pressure of 8/6 mmHg, crepitant rales and
grade 3/6 systolic ejection murmur that was most prominent
over the apex.
Electrocardiography showed ST depression in the inferolat-
eral derivations and ST elevation in aVr.
The echocardiography showed LV systolic dysfunction and
important ischemic mitral regurgitation. There were no signs
of narrowing, insufﬁciency or calciﬁcation of the pulmonary
autograft.
Troponin test was initially negative. Her lipid proﬁle was as
follows: total cholesterol, 5.27 g/l, LDL cholesterol, 4.75 g/l,
HDL cholesterol, 0.29 g/l and TG, 1.19 g/l. The aortogram
showed severe atherosclerosis of the ascending aorta and its
branches (Fig. 2). Coronary angiography demonstratedr patient’s elbow.stenosis in the distal part of the left main and severe three
vessel coronary artery disease (Fig. 3).
The patient presented critical acute myocardial ischemia
immediately after coronary angiography. She was referred
for surgery. The left anterior descending artery was bypassed
using saphenous vein and both right coronary artery and
marginal artery using sequential saphenous vein. The mitral
valve was replaced with mechanic prosthesis. The postopera-
tive course was uneventful.
She was prescribed atorvastatin (40 mg/day) accompanied
by Cholestyramine and diet modulation while waiting for the
beginning of LDL-apheresis.
3. Discussion
FH is an autosomal dominant inherited disorder. Heterozy-
gous FH occurs in approximately 1 in 500 people.1 HFH is
rare and occurs in approximately in 1 in 1 million personsFigure 3 Angiography showing the left main stenosis.
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heterozygous FH.
It is believed that total cholesterol level exceeding
9.68 mmol/l in children whose ﬁrst degree relatives have
hypercholesterolemia are highly suggestive for the disease.2
Premature coronary artery disease and atheromatous
involvement of aortic valve and aortic root are the most
serious complications of HFH which can result in clinical
sequelae even in childhood.3
In our case, the atheromatous involvement of coronary
arteries was present and severe atherosclerotic extent of the
ascending aorta was also documented on the aortography.
Premature atherosclerosis might lead to cardiac ischemia
and coronary revascularization is the last resort to alleviate
the symptoms. This usually presents as angina but may also
present with syncope, dyspnea or sudden death. The predilec-
tion for left main stem has been previously noted in HFH.4
Acute myocardial ischemia may occur after coronary
angiography, especially in patients with HFH and coronary
ostial stenosis. Our patient presented an acute myocardial
ischemia immediately after the coronary angiography.
Currently recommended methods for coronary revasculari-
zation in HFH are coronary artery bypass grafting and stent
implantation but pediatric experience remains scarce.
In fact, there is no available literature concerning the results
of coronary angioplasty in children with HFH with the excep-
tion of few case reports.5,6 Because of the rapid progression of
coronary atherosclerosis in patients with HFH, a surgical
strategy is preferred. Some researchers believe that arterial
revascularization can be the best approach for the affected
children7,8 however, acceptable results from using venous
grafts have been reported previously.9 We used venous graft
because angiography showed severe atherosclerosis of the
ascending aorta and its branches. Concerning the ischemic
mitral regurgitation, mitral valvoplasty was difﬁcult in our
case, so the surgeon opted for a valve replacement.
To the best of our knowledge, she is the youngest patient in
the literature for whom a Ross–Konno procedure, a coronary
artery bypass graft and mitral valve replacement have been
done in childhood.
The management of HFH patients is a challenging job.
Lipid lowering medications and lipid apheresis are two options
to decrease serum cholesterol level; however, the best option to
normalize the lipid proﬁle might be liver transplantation.10
After the coronary artery bypass, we decided to pursue the
statin therapy with lifelong antiaggregant acetylsalicylic acid
treatment. Moreover, we started the therapy with LDL-apher-
esis since this approach is currently the treatment of choice for
HFH and allows a signiﬁcant lowering of cholesterol levels.Stabilization or regression of coronary atherosclerosis has
been reported with LDL apheresis in patients with HFH.10
4. Conclusion
HFH Patients are at increased risk of developing coronary
artery disease and also sudden death unless the condition is
recognized and treated promptly. Surgery remains the most
effective means of prolonging the life of these patients.
Long-term follow up and regular evaluation is recommended.
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